Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI

BACKGROUND: Ferumoxytol is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternative to gadolinium-based contrast agents. On the basis of postmarketing surveillance data, the Food and Drug Administration issued a black box warning regarding the risks of rare but...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiology
Autors principals: Nguyen, Kim-Lien, Yoshida, Takegawa, Kathuria-Prakash, Nikhita, Zaki, Islam H., Varallyay, Csanad G., Semple, Scott I., Saouaf, Rola, Rigsby, Cynthia K., Stoumpos, Sokratis, Whitehead, Kevin K., Griffin, Lindsay M., Saloner, David, Hope, Michael D., Prince, Martin R., Fogel, Mark A., Schiebler, Mark L., Roditi, Giles H., Radjenovic, Aleksandra, Newby, David E., Neuwelt, Edward A., Bashir, Mustafa R., Hu, Peng, Finn, J. Paul
Format: Artigo
Idioma:Inglês
Publicat: Radiological Society of North America 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884068/
https://ncbi.nlm.nih.gov/pubmed/31638489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.2019190477
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars